XETRA:BAYN

Bayer Aktiengesellschaft · XETRA · Healthcare · EUR · FY for 2025

Figures on this page computed 2026-11-08 13:22 UTC

Last close

n/aEUR

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
EUR
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-7.9%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
4.6%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
1.44Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
0.2%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
EUR
- computed

Safety is the furthest below its sector's middle: 0.31 against 0.57 on the market's range.

All from 100

lens 2 of 9

Sales

130

2016-12-31 to 2025-12-31100 at the start130

Sales: 100.00 on 2016-12-31 to 130.43 on 2025-12-31, up 30%.

Profit

-79.9

2016-12-31 to 2025-12-31100 at the start-79.9

Profit: 100.00 on 2016-12-31 to -79.89 on 2025-12-31, down 180%.

Shares in issue

116

2016-12-31 to 2025-12-31100 at the start116

Shares in issue: 100.00 on 2016-12-31 to 116.13 on 2025-12-31, up 16%.

Sales is at 130, Profit is at -80, Shares in issue is at 116, against 100 in 2016.

Sales is at 130, Profit is at -80, Shares in issue is at 116, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100130
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR
Profit, where the first year is 100-80
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR
Shares in issue, where the first year is 100116
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR